Elekta wins public tender to deliver cancer care solutions to China

Health Department to expand its capacity to treat cancer with 15 linear
accelerators from Elekta
STOCKHOLM, January 2 – To help manage the growing incidence of cancer, China’s
Health Department of the People’s Liberation Army (PLA) has ordered a
comprehensive range of clinical solutions from Elekta. Fourteen hospitals around
the country will receive in total 15 linear accelerators (linacs).

The deal includes Elekta Axesse™ linacs with Agility™ multileaf collimators;
Elekta Synergy® linacs and Precise Treatment Systems™ including treatment
planning systems. Elekta’s award-winning MOSAIQ® Radiation Oncology Information
System is also included in the agreement.

Gilbert Wai, Executive Vice President, Region Asia Pacific says: “As the third
major deal in just over a year, this demonstrates the PLA’s confidence in Elekta
as a company and our state-of-the art solutions. And as a Chinese citizen, I
welcome this investment in the country’s health care and am proud that the best
solutions have been chosen.”

The total value of the contract amounts to approximately USD 28 million, and the
order will be booked during Elekta’s second half of fiscal year 2013/14.

Elekta has been present in China since 1982 and is the industry leader in the
Chinese market. China is the company’s second largest market.

# # #

For further information, please contact:
Gert van Santen, Vice President, Corporate Communications, Elekta AB
Tel: +31653561242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 7706702447, e-mail: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 13:00 CET on January 2, 2014.

About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,500 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker STO:EKTAB. Website:
www.elekta.com.